Yarrow Bioscience Inc(YARW)

Biotechnology · New Haven, CT

$19.22-1.08 (-5.32%)

Delayed quote: Oct 6, 2026, 2:49 PM EDT

Yarrow Bioscience (YARW) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T18:59:22.133Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:59:22.133Z.

Quote observation: 2026-10-06T18:54:08.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -23.45
Quote price: 19.16

FMP input reference: a8ce9bd0ffb1cb5d8a686ad50c5c0fc76176a0385911c5cc34bdb5d73fbb2f35

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

YARW Earnings Yield Metrics

EARNINGS YIELD

N/A

YARW Competitors' Earnings Yield

YARW

Yarrow Bioscience Inc

Current

Market Cap

$178.27M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORMP

Oramed Pharmaceuticals Inc.

vs YARW

Market Cap

$181.30M

Earnings Yield

92.78%

TTM Avg

50.31%

3Y Avg

28.59%

5Y Avg

28.59%

CMPX

Compass Therapeutics, Inc.

vs YARW

Market Cap

$182.79M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTN

Canton Strategic Holdings Inc

vs YARW

Market Cap

$183.55M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DERM

Journey Medical Corporation

vs YARW

Market Cap

$173.52M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRQR

ProQR Therapeutics N.V.

vs YARW

Market Cap

$173.76M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANTX

AN2 Therapeutics, Inc.

vs YARW

Market Cap

$184.94M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DTIL

Precision BioSciences, Inc.

vs YARW

Market Cap

$171.26M

Earnings Yield

N/A

TTM Avg

12.15%

3Y Avg

12.15%

5Y Avg

12.15%

CUE

Cue Biopharma, Inc.

vs YARW

Market Cap

$170.21M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORGO

Organogenesis Holdings Inc.

vs YARW

Market Cap

$169.85M

Earnings Yield

N/A

TTM Avg

4.56%

3Y Avg

2.71%

5Y Avg

6.34%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Yarrow Bioscience Inc (YARW)	$178.27M	N/A	N/A	N/A	N/A
Oramed Pharmaceuticals Inc. (ORMP)vs ›	$181.30M	92.78%	50.31%	28.59%	28.59%
Compass Therapeutics, Inc. (CMPX)vs ›	$182.79M	N/A	N/A	N/A	N/A
Canton Strategic Holdings Inc (CNTN)vs ›	$183.55M	N/A	N/A	N/A	N/A
Journey Medical Corporation (DERM)vs ›	$173.52M	N/A	N/A	N/A	N/A
ProQR Therapeutics N.V. (PRQR)vs ›	$173.76M	N/A	N/A	N/A	N/A
AN2 Therapeutics, Inc. (ANTX)vs ›	$184.94M	N/A	N/A	N/A	N/A
Precision BioSciences, Inc. (DTIL)vs ›	$171.26M	N/A	12.15%	12.15%	12.15%
Cue Biopharma, Inc. (CUE)vs ›	$170.21M	N/A	N/A	N/A	N/A
Organogenesis Holdings Inc. (ORGO)vs ›	$169.85M	N/A	4.56%	2.71%	6.34%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

YARW Earnings Yield Metrics

YARW Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics